Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Retrospective, Longitudinal Multi-Center Study of Radium-223 in Patients With Metastatic Castration-Resistant Prostate Cancer

NCT03419442 is registered in ClinicalTrials.gov with Bayer as lead sponsor.

NCT NCT03419442
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03419442 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Retrospective, Longitudinal Multi-Center Study of Radium-223 in Patients With Metastatic Castration-Resistant Prostate Cancer
Lead sponsor
Bayer
Phase
Observational
Overall status
Completed
Start date
December 3, 2018
Completion date
October 22, 2019
Enrollment
150 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

prostate cancer, castration resistant